Trade Akoya Biosciences, Inc. - AKYA CFD
Add to favourite- Summary
- Historical Data
Spread | 0.04 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 2.42 |
Open | 2.45 |
1-Year Change | -63.49% |
Day's Range | 2.41 - 2.47 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 25, 2024 | 2.42 | 0.06 | 2.54% | 2.36 | 2.52 | 2.35 |
Jul 24, 2024 | 2.37 | -0.02 | -0.84% | 2.39 | 2.43 | 2.36 |
Jul 23, 2024 | 2.44 | 0.15 | 6.55% | 2.29 | 2.46 | 2.25 |
Jul 22, 2024 | 2.36 | 0.04 | 1.72% | 2.32 | 2.38 | 2.26 |
Jul 19, 2024 | 2.33 | -0.02 | -0.85% | 2.35 | 2.39 | 2.32 |
Jul 18, 2024 | 2.39 | -0.09 | -3.63% | 2.48 | 2.60 | 2.34 |
Jul 17, 2024 | 2.58 | 0.12 | 4.88% | 2.46 | 2.67 | 2.45 |
Jul 16, 2024 | 2.61 | 0.29 | 12.50% | 2.32 | 2.61 | 2.29 |
Jul 15, 2024 | 2.31 | 0.09 | 4.05% | 2.22 | 2.35 | 2.20 |
Jul 12, 2024 | 2.29 | 0.09 | 4.09% | 2.20 | 2.31 | 2.20 |
Jul 11, 2024 | 2.23 | 0.19 | 9.31% | 2.04 | 2.28 | 2.04 |
Jul 10, 2024 | 2.06 | 0.04 | 1.98% | 2.02 | 2.09 | 1.99 |
Jul 9, 2024 | 2.04 | -0.01 | -0.49% | 2.05 | 2.10 | 1.97 |
Jul 8, 2024 | 2.06 | -0.03 | -1.44% | 2.09 | 2.12 | 2.05 |
Jul 5, 2024 | 2.06 | -0.02 | -0.96% | 2.08 | 2.09 | 2.03 |
Jul 3, 2024 | 2.11 | -0.06 | -2.76% | 2.17 | 2.17 | 2.08 |
Jul 2, 2024 | 2.16 | 0.01 | 0.47% | 2.15 | 2.19 | 2.09 |
Jul 1, 2024 | 2.18 | -0.17 | -7.23% | 2.35 | 2.35 | 2.13 |
Jun 28, 2024 | 2.31 | -0.07 | -2.94% | 2.38 | 2.43 | 2.26 |
Jun 27, 2024 | 2.41 | -0.03 | -1.23% | 2.44 | 2.55 | 2.38 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Akoya Biosciences, Inc. Company profile
About Akoya Biosciences Inc
Akoya Biosciences, Inc. is a life sciences technology company. The Company deliveries spatial biology solutions, which is focused on transforming discovery and clinical research. Spatial biology technology enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and and PhenoImager platform, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research. It provides PhenoImager HT, which is a digital pathology slide scanner featuring MOTiF whole-slide multispectral scanning of up to seven biomarkers with an 80-slide capacity. It offers contract research services laboratory, which is called as advanced biopharma solutions.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Akoya Biosciences Inc revenues increased 29% to $54.9M. Net loss applicable to common stockholders increased from $21.8M to $44.4M. Revenues reflect Consumables segment increase of 68% to $14.3M, Instruments segment increase of 21% to $28.7M, North America segment increase of 39% to $28M, EMEA segment increase of 21% to $14.4M. Higher net loss reflects Selling.
Industry: | Advanced Medical Equipment & Technology (NEC) |
100 Campus Drive
6th Floor
MARLBOROUGH
MASSACHUSETTS 01762
US
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com